Status:
UNKNOWN
Prestilol(Perindopril+Bisoprolol) in Therapy of Patients With Atrial Fibrilation
Lead Sponsor:
Aversi Clinic
Conditions:
Patient Participation
Eligibility:
All Genders
18-70 years
Brief Summary
The study aims to evaluate the effectiveness and safety of oral fixed-dose combination of bisoprolol/perindopril in patients with permanent atrial fibrillation
Eligibility Criteria
Inclusion
- permanent atrial fibrillation with normal EF -
Exclusion
- AF with decreased EF
- \-
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04484688
Start Date
August 1 2020
End Date
December 1 2021
Last Update
July 23 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Aversi Clinic
Tbilisi, Georgia
2
Aversi Clinic
Tbilisi, Georgia